← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Stuka Paul
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001528577
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 10
- Purchases · 24M
- 11
- Average purchase
- $30.4K
- Median purchase
- $17.6K
- Gross purchase value
- $334.1K
Companies: InspireMD, Inc.
11 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-05-29 | InspireMD, Inc. | NSPR | Director | $17.6K | Open filing |
| 2026-05-15 | InspireMD, Inc. | NSPR | Director | $17.4K | Open filing |
| 2026-05-13 | InspireMD, Inc. | NSPR | Director | $88.0K | Open filing |
| 2026-05-12 | InspireMD, Inc. | NSPR | Director | $88.0K | Open filing |
| 2026-05-08 | InspireMD, Inc. | NSPR | Director | $9.0K | Open filing |
| 2026-02-23 | InspireMD, Inc. | NSPR | Director | $4.9K | Open filing |
| 2025-12-11 | InspireMD, Inc. | NSPR | Director | $9.2K | Open filing |
| 2025-12-08 | InspireMD, Inc. | NSPR | Director | $9.4K | Open filing |
| 2025-12-05 | InspireMD, Inc. | NSPR | Director | $18.7K | Open filing |
| 2025-11-13 | InspireMD, Inc. | NSPR | Director | $21.8K | Open filing |
| 2025-08-01 | InspireMD, Inc. | NSPR | Director | $50.0K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 0/10
- Large purchase ≥ $100k
- 0/11
- Cluster buying · 15D
- 5/11
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.